PUNE, India, December 1, 2015 /PRNewswire/ --
According to the Market Research Report "North American Orthobiologics Market by Type (Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation), by End-User (Hospitals, Point-of-Care Testing) - Analysis and Forecast to 2019", the North America Orthobiologics market was valued at $1,724.5 million in 2014 and is estimated to grow to around $2,493.5 million by 2019, at a CAGR of 7.7% from 2014 to 2019. The orthobiologics market is a rewarding market, which represents a number of opportunities for its stakeholders. The North America orthobiologics report defines and segments the concerned market with analysis and forecast of revenue.
Browse through the TOC of the North America orthobiologics market, to get an idea of the in-depth analysis provided. This also provides a glimpse of the segmentation of Orthobiologics market in the same region, and is supported by various tables and figures.
Early buyers will receive 10% customization on this report.
Orthobiologics are substances used by orthopedic surgeons for healing bone injuries. These substances are derived naturally from the human body. The changing preferences of the people from mechanical implants to biological implants accompanied by the rising awareness levels of orthobiologics are driving the growth of this market. The orthobiologics market has seen impressive growth since 2012 owing to the increased research as well as the rising demand for such products due to the benefits associated with them.
The U.S. orthobiologics market had the largest share in North America, and it is slated to grow further due to the augmented growth in research, and increase in the aging population.
The Canadian region is anticipated to grow further due to growing investments in research, higher growth rate of aging population, and increasing cases of road accidents. However, reimbursement concerns & stringent regulations, and high cost are some of the factors that could hinder the growth of this market.
For more Inquiries: http://www.micromarketmonitor.com/contact/9077664565-inquery_before_buy.html
Key Players of the North America Orthobiologics Market include:
Biomet, Inc. (U.S.), Medtronic, Plc. (U.S.), Integra LifeSciences Corporation (U.S.)., Stryker Corporation (U.S.), Zimmer Holdings, Inc. (U.S.), Tornier, Inc. (Netherlands), NuVasive, Inc. (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Wright Medical Group, Inc. (U.S.)
This market is segmented and forecast on the basis of products and end-users. The North America orthobiologics market is further segmented and forecast on the basis of countries such as the U.S., Canada, and Mexico. This report also includes the market share, value chain analyses, and market metrics such as drivers, restraints, and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players in the market including major companies of the market.
MicroMarket Monitor produces exclusive market research reports, based on real-time data to provide better understanding of the dynamic market conditions of the Healthcare industry. The reports offer in-depth and complete analysis of the regional and country level marketplaces. The research reports for Healthcare industry are updated on quarterly basis and are easily available for purchase through annual subscriptions.
About MicroMarket Monitor:
MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.
Mr. Chandrasekhar K.
UNIT no 802, Tower No. 7, SEZ
Magarpatta City, Hadapsar
Pune, Maharashtra 411013,
SOURCE MicroMarket Monitor